TickerFacts.

Fortrea Holdings Inc. (FTRE): Operating Income

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

-$872.60M
Year ended 2025-12-31
-$10.80M
Trailing 12 months to 2026-06-30
$187.10M2021-12-31: $114.30M2022-12-31: $187.10M2023-12-31: $32.00M2024-12-31: -$161.90M2025-12-31: -$872.60M-$872.60M
2021-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31-$872.60Mn/m2026-02-26, From 2025-01-01
2024-12-31-$161.90Mn/m2026-02-26, From 2024-01-01
2023-12-31$32.00M-82.9%2026-02-26, From 2023-01-01
2022-12-31$187.10Mn/c2025-03-03, From 2022-01-01
2021-12-31$114.30Mn/a2024-03-13, From 2021-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
Fortrea Holdings Inc. (FTRE)2025-12-31-$872.60Mn/m
Natera, Inc. (NTRA)2025-12-31-$309.91Mn/m
RadNet, Inc. (RDNT)2025-12-31$61.99M-40.7%
Guardant Health, Inc. (GH)2025-12-31-$437.25Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$45.11Mn/m
Quest Diagnostics Inc (DGX)2025-12-31$1.56B+15.6%
Labcorp Holdings Inc. (LH)2025-12-31$1.38B+27.4%
Veracyte, Inc. (VCYT)2025-12-31$57.78M+257.9%
CareDx, Inc. (CDNA)2025-12-31-$30.78Mn/m

Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗